Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Morinder G, Mattsson E, Sollander C, Marcus C, Larsson UE
The ADA and the EASD further recommend SGLT2is as first-line therapy in patients with T2DM and heart failure (HF) to reduce the risk of worsening HF [6, 7]
Verdict: Effective, but generally less potent than the newer weekly injectables
doi: 10.3389/fmicb.2017.02429 Received 14 September 2017 Accepted 23 November 2017 Published 14 December 2017 Volume 8 - 2017 Edited by Felipe Lomb, Universidad de Oviedo, Spain Reviewed by Rodolfo Garca-Contreras, Universidad Nacional Autnoma de Mxico, Mexico
[DOI] [PubMed] [Google Scholar] 92.Bourgonje A.R., Feelisch M., Faber K.N., Pasch A., Dijkstra G., van Goor H
Kidney hemodynamic effects of angiotensin receptor blockade, sodium-glucose Cotransporter-2 inhibition alone, and their combination: a crossover randomized trial in people with type 2 diabetes
US$ 26.45
US$ 24.28
US$ 25.16
